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ABSTRACT  
 
Purpose: 
The aim of this study was to establish the level of ATP release by the urothelium from 
patients with painful bladder syndrome and compare it with that from the normal human 
urinary bladder. 
 
Methods:  
Biopsies of urothelium, obtained from patients with painful bladder syndrome were 
subjected to stretch (by 130 and 150% of the original length) and electric stimulation 
(10Hz). A luciferase assay was used to quantify ATP release. The neurotoxin, 
tetrodotoxin was used to block the neuronal source of ATP release. 
 
Results:  
There was a significantly greater release of ATP following mechanical stretch of the 
urothelium from painful bladders compared with control bladders.  The increase in ATP 
release was statistically significant whether expressed in absolute values (3791.4±667.9 
pM/g of tissue compared with 77.6±16.2 pM/g of tissue for controls) or as the increase 
over basal levels (182.2±24.8 % increase above baseline compared with 75.4±21.7 % 
over basal levels for controls).   
Similarly, there was a significant release of ATP following electric field stimulation of 
the urothelium from painful bladders (1348.6±278.2pM/g of tissue) compared with 
normal (61.7±10.1 pM/g of tissue) [p<0.005], a 730.4±45.8 % increase above the basal 
level compared with an increase of 37.9±4.4 % for normal bladders [p<0.001]). The 
source of ATP release was mainly non-neuronal, 91 % for the painful bladders and 81 % 
for controls. 
 
Conclusions:  
There is a significantly increased level of ATP release from the urothelium of painful 
bladders in comparison to normal bladders suggesting an important potential functional 
role for ATP in this condition.  
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INTRODUCTION 
 
Adenosine triphosphate (ATP) has been increasingly recognised as an important sensory 
neurotransmitter. A number of studies have supported the idea that mechanical stimuli 
can evoke the release of ATP from epithelial cells lining "tubes" or "sacs" such as the 
urinary bladder [1]. This extra-cellular ATP, which is most likely urothelial in origin, has 
been implicated in the distension-evoked activation of bladder afferents [2]. Once 
released from epithelial cells after bladder stretch, ATP is thought to activate purinergic 
receptors on suburothelial sensory nerves and thus may play an important role in sensory 
functions such as nociception [3].  
Further support for this theory comes from the study of mice lacking the P2X3 sensory 
purinergic receptor subunit (normally expressed by a subset of bladder afferents), which 
exhibit normal distension-evoked urothelial ATP release but diminished reflex bladder 
contractions and voiding behavior and a reduction in the behavioural (pain) response to 
the injection of ATP [4].  Based on these observations it has been suggested that 
mechanical stretch evoked ATP release from the urothelium may play a major role in 
both volume and pain-mediated reflexes. Suggesting that the purinergic system is 
important not only in normal bladder function but may have an important pathogenic role 
in functional disorders of  the bladder.  
Patients with painful bladders form a heterogeneous group based on a diagnosis of 
exclusion rather than a precise patho-physiology. This study was aimed to establish the 
level of ATP release by the urothelium from painful bladders and compare it with that 
from the normal human urinary bladder. 
 
 
METHODS 
 
The experiments were performed using tissue from the bladder dome.  Patients were 
diagnosed as having painful bladder syndrome on the basis of the symptoms of frequency 
due to bladder pain, leading to a reduced functional capacity but in the absence of 
urodynamically assessed detrusor overactivity.  The urothelium from painful bladders 
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was obtained by cold cup biopsy in patients undergoing cystodistension following full 
informed consent and approval from the local ethics committee (n=8). The urodynamic 
studies in this group showed a stable bladder during the filling phase but with small 
capacity and perception of pain with further filling. These patients had a mean maximum 
cystometric capacity of 206mL (range=168-280mL). Cystoscopy in these patients 
showed no obvious bladder pathology. Control bladders were obtained from patients with 
urodynamically proven stable bladders undergoing surgery for stress urinary incontinence 
(n=4) and from patients undergoing cystectomy for cancer who had no history of 
receiving radiotherapy or any form of intravesical treatment and had no lower urinary 
tract symptoms that would suggest a functional bladder disorder (n=5). The tissue was 
taken from a site distant to the tumour from a normal looking bladder area. 
 
Tissues were set up under 1g tension in 2.5mL tissues baths containing Krebs bicarbonate 
solution (composition in mM/L: NaCl 118.4, NaHCO3 24.9, KCl 4.7, CaCl 2 1.9, MgSO4 
1.15, KH2 PO4 1.15, glucose 11.7) at 37°C and gassed with a mixture of 95% O2 and 5% 
CO2   The tissues were placed between two platinum-wire loop-electrodes and, using 
suture silk, the bottom end of the tissues were secured to a tissue holder. The upper ends 
were attached (with suture silk) to isometric force transducers (UFI model 1030). The 
transducers were connected to a Cambridge Electronic Design (CED) data acquisition 
system, allowing changes in isometric tension to be recorded. Tissues were equilibrated 
for at least one hour with the bathing medium changed at 15-minute intervals. This 
washing removed the artefact of increased ATP release caused by surgical trauma.  The 
urothelium was then mechanically stretched by 130% and 150% of the original length 
and bath samples taken 2 minute following the stretch for quantification of ATP release. 
The tissues were also subjected to electric field stimulation (EFS) at 10Hz (40V, 0.2msec 
pulse-width for 60s) using a Digitimer Powerstim Stimulator and ATP release assessed 
[5]. 
 
To enable the calculation and separation of neuronal and non-neuronal sources of ATP, 
release induced by mechanical and electrical field stimulation was determined following 
a 20 minutes incubation of the tissues with the neurotoxin, tetrodotoxin (5µM). All the 
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tissues were weighed at the end of each experiment. The ATP released was expressed in 
pM per gram of tissue and as percentage increase above the basal (resting) level.  
 
Luciferase Assay: ATP release was quantified by luminometry by the luciferin-
luciferase assay using ATP reagent HS (BioThema, Haninge). 50µl of the ATP standards, 
the samples and the blank (for measuring the background luminosity) were placed in a 
96-well microplate (NUNCTM, Denmark), which was followed by automatic addition of 
100µl of luciferin-luciferase reagent in the ‘Lucy Anthos 1’ luminometer (Anthos 
Labtech Instruments, Austria). The analysis was performed using ‘Stingray’ software 
(Dazdaq Ltd, UK). The ATP concentration was calculated from calibration curves 
constructed from the ATP standards with correlation coefficient varying from 0.998 to 
0.999. The increase in ATP was expressed as the percentage rise above the baseline or as 
amount of ATP in pM per gram of tissue.  
 
Statistical analysis was performed using the Student’s t-test, with P<0.05 being taken as 
significant.  
 
 
 
RESULTS 
 
At the start of the experiment the basal level of ATP in the bath before stretching or 
electrically stimulating the tissue was 45.7±4.9pM g-1 tissue.  Mechanical stretch of the 
urothelium increased ATP levels by 108.4±19.3 % following 130% stretch and by 
182.2±24.8 % following a 150% increase in tissue length (Figure 1, Table 1).  Electrical 
field stimulation also resulted in an enhanced ATP release from the urothelium, 10Hz 
stimulation increasing ATP bath concentrations by 730.4±45.8 % (Table 2).  The 
presence of tetrodotoxin (5µM) did not significantly affect ATP release induced by 
stretch indicating a non-neuronal source of ATP (p=NS).  In contrast, electrical field 
stimulation induced release was reduced by 79% in the presence of this neurotoxin 
(P<0.005) (Table 2).     
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For urothelium from painful bladders the basal release of ATP was greatly enhanced, 
bath concentrations rising from 45.7±4.9 pM g-1 to 1321.1±475.7 pM g-1 tissue (P<0.01, 
n=8).  Following mechanical stretch the difference from control tissue was even greater 
and the release of ATP induced by a 130% stretch was 2944.6±565.9 pM g-1 compared 
with only 67.5±13.2 pM g-1 for control tissue (P<0.001).  Similarly for the 150% stretch, 
ATP release was greatly enhanced over that of control tissue, mechanical stimulation 
increasing ATP release to 3791.4±667.9 pM g-1 in the painful bladders as compared to 
77.6±16.2 pM g-1 for control tissues (P<0.001).  This large increase in ATP release was 
statistically significant whether the data were expressed in absolute values, as the 
increase above basal levels or as a percentage of the initial basal release (Figure 2, Table 
2).  As with the control tissues, ATP release was not significantly altered in the presence 
of tetrotodoxin (5µM) indicating a non-neuronal origin. 
 
Following electrical field stimulation the release of ATP from the urothelium of painful 
bladders was large (730.4 ± 45.8% above basal levels) and this was significantly greater 
than that obtained in control tissues.  This enhanced release was statistically significant 
whether expressed in absolute values, the increase above basal levels or as a percentage 
increase over basal levels (Figure 2, Table 2).  As for control tissues, the ATP release 
induced by electrical field stimulation was significantly reduced (P<0.05) in the presence 
of tetrodotoxin; this inhibition (75%) being similar to that obtained for control tissue 
(78%). 
 
. 
DISCUSSION 
 
There has been an increasing awareness that normal bladder contraction may be more 
significantly controlled by afferent neuronal activity than previously recognised. Whilst 
in a normal bladder, the afferent activity is mediated via the Aδ-fibres [6], in pathological 
conditions like painful bladder syndrome, it may occur via normally inactive C-fibres [7]. 
In theory, increased afferent activity could be of great importance in the development of 
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painful bladder disorders, where the bladder is hypersensitive to stretch and the resulting 
sensation may be perceived as pain. 
Several studies have supported the important afferent sensory role for ATP in the bladder. 
In rats, it has been reported that there is a significant reduction in the pelvic afferent 
nerve activity (by 75%) in bladders exposed to intravesical α-β-methylene ATP that acts 
by desensitising the purinergic (P2X) receptors [8]. If ATP is a sensory neurotransmitter, 
then conceptually, an increased purinergic activity may lead to a condition where the 
bladder is oversensitive to distension resulting in so called ‘painful bladder syndrome’. 
Painful bladder syndrome/Interstitial Cystitis (IC)” is a broad term that implies painful 
distension of the bladder and includes a wide spectrum of pathological conditions [9]. 
There is a very sparse data available regarding the pharmacology of this disorder mainly 
because of limited knowledge about its patho-physiology and most theories about the 
patho-physiology of this condition have not been rigorously tested. 
The atropine resistant contractile component in detrusor strips from patients with so 
called “interstitial cystitis” has been shown to be about 43% of the total response, while 
this component has not been observed in controls [10]. Recent studies have suggested an 
increased release of ATP from the urothelium of cats with ‘interstitial cystitis’ (feline 
interstitial cystitis; FIC), which are used as an animal model for ‘interstitial cystitis’ [11] 
and also from the cultured human urothelium and urine from patients with ‘interstitial 
cystitis’ [12, 13]. In this study, we used the urothelium from patients with painful 
bladders, which was stimulated using mechanical stretch and electric field stimulation 
and the consequential ATP release was quantified. There was a significantly increased 
release of ATP from this urothelium following both electric field stimulation as well as 
mechanical stretch, in comparison to the normal bladders. If ATP is a sensory 
neurotransmitter in bladder responsible for bladder sensation and nociception, as 
suggested by Burnstock et al (2000) [3] and Ferguson et al (1999) [14], this remarkably 
increased release of ATP from the urothelium of painful bladders would explain the 
different symptoms resulting from this disorder namely: bladder hypersensitivity, pain, 
smaller functional bladder capacity and the resulting urinary frequency along with 
urgency. However, the increased ATP release may not be the only purinergic component 
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responsible for this condition; the distribution and quantity of the sensory purinergic 
receptors (P2X3) may also contribute.  
Furthermore, the major source for ATP release following mechanical stretch, which is 
probably a more physiological stimulus, is non-neuronal. This further supports the view 
that it is the urothelially released ATP, which is principally responsible for bladder 
sensation as suggested by Ferguson (1999) [14] or an increased bladder sensation as in 
this case. 
This study provides a direct evidence of significantly increased release of ATP from the 
urothelium of painful bladders as compared to normal situation. Adenosine triphosphate 
thus, may have an important role in the mechanisms governing abnormal bladder 
sensation. This study has suggested an increased purinergic activity in terms of an 
increased ATP release in painful bladders as compared to normal bladders. This would 
explain most symptoms resulting from this condition and may provide a target for the 
development of new therapies for different conditions that are included in this category. 
 
 
 
CONCLUSIONS 
 
There is a significantly increased level of ATP release from urothelium of painful 
bladders in comparison to normal bladders suggesting an important role for ATP in this 
condition. This study provides direct evidence for the increased purinergic activity in 
painful disorders of the bladder. 
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Table 1: ATP release following mechanical stretch and electric field stimulation 
ATP release with Mechanical stretch (pM/gm tissue) ATP release with Electrical 
stimulation (pM/gm tissue) 
 
Baseline 130% 150% Baseline 10 Hz 
Painful bladder 
Urothelium 
1321.1±475.7† 2944.6±565.9* 3791.4±667.9* 496.4±21.1† 1348.6±278.2* 
Control 45.7±4.9 67.5±13.2 77.6±16.2 45.8±5.1 61.7±10.1 
* p<0.005, compared with baseline value  †p<0.01, compared with control urothelium 
 
 
 
Table 2: Effect of TTX (5μM) on ATP release following electrical and mechanical 
stimulation of painful bladder and normal urothelium. 
ATP release with Mechanical 
stretch (150% elongation) 
(% Increase over baseline) 
ATP release with Electrical 
stimulation (10Hz)  
(% Increase over baseline) 
 
TTX absent TTX present TTX absent TTX present 
Painful bladder 
urothelium 
182.2±24.8* 165.2±40.1† 730.4±45.8* 185.9±38.1‡ 
Control 75.4±21.7 60.9±20.1 37.9±4.4 8.7±2.2 
*p<0.005, compared with control urothelium       †p=0.2[NS] compared with TTX absent 
‡p<0.001,compared with TTX absent 
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Figure 1. ATP release following mechanical stretch of painful bladder urothelium vs. 
normal urothelium (p<0.005). 
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Figure 2. Bar chart showing relative reduction in ATP release from the urothelium of 
painful bladder, following TTX on mechanical stretch (p=NS). 
